Richard J. Katz, MD

Despite advances in cardiac testing, noninvasive methodologies remain limited in their accuracy to (1) determine the etiology of chest pain; (2) detect preclinical coronary artery disease; and (3) track the progression of atherosclerotic lesions in native and revascularized coronary vessels.